MARRONE BIO INNOVATIONS INC | 2013 | FY | 3


The following table summarizes information about the Company’s common stock warrants outstanding as of December 31, 2013 (in thousands, except exercise price data):

 

DESCRIPTION

  ISSUE DATE   EXPIRATION
DATE (1)
  NUMBER OF
SHARES
SUBJECT TO
WARRANTS
ISSUED
    EXERCISE
PRICE
 

In connection with April 2013 Junior Secured Promissory Note (Additional Common Stock Warrants)

  April 2013   October 2015     118      $ 8.40   

In connection with June 2013 Credit Facility (June 2013 Warrants)

  June 2013   June 2023     33      $ 8.40   
     

 

 

   
        151     
     

 

 

   

 

(1) 

Both the common stock warrants expire upon the earlier to occur of (i) the date listed above; (ii) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any transfer of more than 50% of the voting power of the Company, reorganization, merger or consolidation, but excluding any merger effected exclusively for the purpose of changing the domicile of the Company) or (iii) a sale of all or substantially all of the assets of the Company; unless the Company’s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Company’s acquisition or sale or otherwise) hold at least fifty percent (50%) of the voting power of the surviving or acquiring entity.


us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock